Steatohepatitis : NASH and ASH /

Bibliographic Details
Corporate Author: Falk Symposium Hague, Netherlands
Other Authors: Leuschner, U., James, O. F. W., Dancygier, Henryk
Format: Conference Proceeding Book
Language:English
Published: Dordrecht : Boston : Kluwer Academic, [2001]
Series:Falk symposium ; 121.
Subjects:
Table of Contents:
  • Sec. I. Epidemiology, diagnosis and definition of NASH
  • Epidemiology and risk factors for fatty liver
  • Non-alcoholic liver disease : natural history
  • Pathology and classification of non-alcoholic steatohepatitis
  • Non-alcoholic steatohepatitis : grading and staging the histological lesions
  • Diagnosis of non-alcoholic steatohepatitis
  • Sec. II. Pathogenic mechanisms of NASH and ASH
  • The genetic basis for non-alcoholic and alcoholic steatohepatitis
  • Oxidative stress in alcoholic and non-alcoholic steatohepatitis
  • Endotoxins and cytokines in the pathogenesis of non-alcoholic steatohepatitis
  • Cyclooxygenase-2 : a potential target for the prevention and treatment of alcoholic liver disease
  • Inducible cytochromes P450 and lipid peroxidation in non-alcoholic steatohepatitis
  • Mitochondrial dysfunction in hepatitic steatohepatitis
  • Role of iron in non-alcoholic and alcoholic steatohepatitis
  • Insulin resistance in non-alcoholic fatty liver disease : a clinical perspective
  • Sec. III. Aetiology of NASH and ASH
  • Obesity and non-alcoholic steatohepatitis
  • Non-alcoholic steatohepatitis and intestinal disease
  • Drugs and non-alcoholic steatohepatitis
  • Failure of regeneration of the steatotic liver : disruption at two different levels in the regeneration pathway
  • Obesity and cryptogenic cirrhosis
  • Diet and alcoholic steatohepatitis
  • Gender and alcoholic steatohepatitis
  • The intrahepatic and extrahepatic metabolic abnormalities associated with non-alcoholic steatohepatitis
  • Sec. IV. Therapeutic options for NASH
  • Treatment of non-alcoholic steatohepatitis : role of ursodeoxycholic acid
  • Clofibrate and other lipid-lowering drugs in the treatment of non-alcoholic steatohepatitis
  • Alpha-tocopherol and antioxidants in the treatment of non-alcoholic steatohepatitis
  • Diet and exercise : important first steps in the therapy of non-alcoholic fatty liver disease
  • Sec. V. Histopathology and clinical aspects of ASH
  • Histological hallmarks of alcoholic steatohepatitis
  • Alcoholic and non-alcoholic steatohepatitis : histological differences and pathogenesis of cytoskeleton alterations
  • Clinical spectrum of alcoholic steatohepatitis
  • Prognosis of alcoholic hepatitis
  • Carbohydrate-deficient transferrin : clinical value and pitfalls
  • Sec. VI. Alcohol and cytotoxicity
  • Alcohol and mitochondrial function
  • Role of bile acids blocking ethanol-induced apoptosis
  • Interactions of alcohol, steatosis and hepatitis C
  • Sec. VII. Management of alcoholic hepatitis
  • Metabolic and nutritional interventions in the treatment of alcoholic hepatitis
  • Alcoholic hepatitis steroid yes?
  • Alcoholic hepatitis : no glucocorticosteroids?
  • Beneficial effects of polyenylphosphatidylcholine in alcoholic and non-alcoholic liver injury
  • S-adenosylmethionine in alcoholic liver disease